You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
17 August 2026 - Biopharmaceutical company AstraZeneca (LSE: AZN) (STO: AZN) (NYSE: AZN) on Monday announced positive high-level results from the SAFFRON Phase III trial, showing Tagrisso (osimertinib) plus Orpathys (savolitinib) delivered statistica...
17 August 2026 - Biopharmaceutical company HUTCHMED (China) Limited (Nasdaq: HCM) (AIM: HCM) (HKEX: 13) on Monday announced positive high-level results from the SAFFRON Phase III trial, showing that ORPATHYS plus TAGRISSO delivered statistically sign...
17 August 2026 - BioSapien, a California-based biotech company, announced on Friday that it has been nominated by The Galien Foundation, a global institution involved in honouring innovators in life sciences, in the 'Best Startup' category ...
17 August 2026 - Phanes Therapeutics Inc, a California-based, clinical-stage biotech company involved in innovative drug discovery and development in immuno-oncology, announced on Friday that the US Food and Drug Administration (FDA) has granted Fast...
17 August 2026 - Shanghai Ark Biopharmaceutical Co Ltd (ArkBio) a China-based biopharmaceutical company, announced on Friday that the US Food and Drug Administration (FDA) has approved ziresovir (AK0529) for a phase II clinical trial in the severely ...
14 August 2026 - Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a San Francisco-based commercial stage biotechnology company, announced on Thursday that VEPPANUTM (vepdegestrant) is now available by prescription in the United States for the treatment of...
14 August 2026 - Innorna, a Hong Kong-based clinical-stage biotech company advancing RNA medicines, announced on Thursday that it has been nominated for the 2026 Prix Galien USA Best Startup Award.Innorna was shortlisted in the Best Startup category,...